Gynecology/Menopause/Family Planning

Friday, December 1, 2017                                                                                                                                             Hall C

08:30-10:00 MENOPAUSE: DISEASE PREVENTION
Capsule The debate continues: Can HRT prevent post-menopausal morbidity?
Chairpersons Xiangyan Ruan, China
Marco Gambacciani, Italy
HRT: WHI authors claim wrong data interpretation
Alfred Mueck, Germany
Debate: HRT – Cardiovascular risk or prevention?
Risk: Sven Skouby, Denmark
Prevention: Christian Egarter, Austria
Discussion
HRT: How to prevent and/or treat (uterine) bleeding problems
Alfred Mueck, Germany
10:00-10:20 Coffee break & poster viewing
10:20-11:50 NON-MEDICAL OPTIONS TO TREAT VAGINAL ATROPHY
Capsule The current worldwide laser hype offers treatment for “Atrophic vaginitis” including alleviation of dryness, burning, irritation, sexual symptoms, lack of lubrication and urinary symptoms. What are the proofs? Alleviation?
Chairpersons Irene Lambrinoudaki, Greece
Marco Gambacciani, Italy
Non-hormonal options to treat vaginal atrophy: A pathophysiologic perspective
Alessandra Graziottin, Italy
Vaginal erbium laser for genitourinary syndrome of menopause
Marco Gambacciani, Italy
Vaginal Lactobacillus: Biofilm formation in vivo – clinical implications
Gary Ventolini, USA
11:50-12:10 Break
12:10-13:40 VULVOVAGINAL PROBLEMS ON THE RISE: ARE WE READY?
Chairpersons Jorma Paavonen, Finland
Gilbert Donders, Belgium
Vulvar vestibulitis syndrome: Conservative management or surgery?
Päivi Tommola, Finland
Jorma Paavonen, Finland
Abnormal vaginal microbiome: Is this bacterial vaginosis or aerobic vaginitis? How to develop a pragmatic clinical algorithm
Gilbert Donders, Belgium
Vulvar dermatoses: Natural history of lichen sclerosus and lichen planus; risk for malignancy
Maija Jakobsson, Finland
Discussion
13:40-14:30 Lunch break
14:30-16:30 BREAST CANCER RISK FROM HORMONAL TREATMENT
Capsule Is a knee-jerk association of hormonal treatment with breast cancer overstated?
Chairpersons Tommaso Simoncini, Italy
Santiago Palacios, Spain
Progestins and breast cancer risk
Ludwig Kiesel, Germany
How can we reduce the HRT related breast cancer risk?
Marco Gambacciani, Italy
Impact of different SERMs on breast cancer
Santiago Palacios, Spain
Progestins and cardiovascular aspects
Christian Egarter, Austria
Special countercurrent lecture
Estrogens protect against breast cancer and can be used in selected cases for the treatment of breast cancer
Herjan Coelingh Bennink,
The Netherlands
16:30-16:50 Coffee break & poster viewing
16:50-18:20 OBESITY IS AN INDEPENDENT RISK FACTOR OF MENOPAUSE
In cooperation with the European Menopause and Andropause Society (EMAS)
Capsule Hormonal changes are not necessarily responsible for menopausal weight gain. Other factors such as lifestyle, the right diet and physical activity are important factors in controlling age related and menopausal obesity
Chairpersons Sven Skouby, Denmark
Alessandra Graziottin, Italy
Prevention of peri-menopausal obesity by diet and life-style intervention
Irene Lambrinoudaki, Greece
The implications of fat accumulation during menopause
Tommaso Simoncini, Italy
Managing obesity: The place of bariatric surgery
Gerhard Prager, Austria
Exercising during and after menopause: Biological benefits to increase longevity in health
Alessandra Graziottin, Italy

Saturday, December 2, 2017                                                                                                                                         Hall C

08:30-10:00 HPV SCREENING AND SCREENING STRATEGIES
Capsule Most European recommendations support the adoption of validated HPV tests as the stand-alone primary screening tool. Coordinated strategies of screening and vaccination are the subject of intense research and evaluation
Chairpersons F. Xavier Bosch, Spain
Thomas Iftner, Germany
Tests for HPV screening: Clinical validation
Thomas Iftner, Germany
Guidelines for HPV screening in Europe
Mario Poljak, Slovenia
The need for coordinated programs of vaccination and screening
F. Xavier Bosch, Spain
Discussion: The impact of HPV screening in the re-organization of health services
10:00-10:20 Coffee break & poster viewing
10:20-12:05 HPV VACCINES: LIGHTS AND SHADOWS
Capsule Despite massive data confirming the effectiveness and safety of HPV vaccines, some vaccination programs in the world have been challenged by non-scientifically supported claims of side effects
Chairpersons F. Xavier Bosch, Spain
Elmar Joura, Austria
The adoption of HPV vaccines in the world and the axis of assessment of vaccine safety
F. Xavier Bosch, Spain
The promises of the second-generation HPV vaccines
Elmar Joura, Austria
Vaccine confidence and vaccine hesitancy: The case in Denmark
Susanne Krüger Kjaer, Denmark
Discussion: The role of the gynecologists in HPV vaccination
Oral abstract contribution to the panel:
A novel HPV detection method
Changping Zou, USA
12:05-12:10 Break
12:10-13:40 4 METHODS FOR CREATING NEOVAGINA – AND THE WINNER IS…
In cooperation with the International Federation of Infant and Juvenile Gynecology (FIGIJ)
Capsule Neovagina is a dramatic surgery for the adolescent. This innovative choice may ease the experience
Chairpersons George K. Creatsas, Greece
Pierluigi Benedetti Panici, Italy
Gabriele Tridenti, Italy
Neovagina using autologous cultured vagina tissue
Pierluigi Benedetti Panici, Italy
Vulvovaginoplasty
George K. Creatsas, Greece
Creation of a neovagina by Davydov’s laparoscopic modified technique in patients with Rokitansky syndrome
Leila Adamyan, Russia
Luohu Procedure in Female Genital Tract Congenital Malformation (The Experience Based on 1000+ Vaginoplasty)
Guangnan Luo, China
13:40-14:30 Lunch break
14:30-16:30 WILL HRT EVER REBOUND TO PRE-WHI?
Capsule 15 years after WHI, is it still possible that without a paradigm shift the HRT will never rebound to its previous level?
Chairpersons Andrea R. Genazzani, Italy
Christian Egarter,
Austria
Debate: HRT: Have the risks been overestimated? Will it rebound to the pre-WHI era?
Yes: Tommaso Simoncini, Italy
No: Sven Skouby, Denmark
Discussion
Debate: Vaginal application of sex steroids: The future in women’s health?
Yes: Andrea R. Genazzani, Italy
No: Alessandra Graziottin, Italy
Discussion
Special countercurrent lecture
Ovarian tissue re-implantation: The HRT of the future?
Jacques Donnez, Belgium
16:30-16:50 Coffee break & poster viewing
16:50-18:20 OCs COMPLICATIONS: IMPACT ON DEPRESSION AND SUICIDE
Capsule Did we miss or downplay the risks and complications of OCs?
Chairpersons Santiago Palacios, Spain
Mireille Merckx, Belgium
Contraceptives and thrombotic risks: What is the true risk?
Sven Skouby, Denmark
Debate: Is depression a major or a minor side effect?
Yes, depression is a major side effect
Øjvind Lidegaard, Denmark
No, depression is not a major side effect
Andrea R. Genazzani, Italy
Discussion
OCs and sexual dysfunction
Alessandra Graziottin, Italy

*The scientific program is subject to change.